col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt

Verlag: Acta Pharmaceutica Hungarica

6 Ergebisse       Seite 1

 [1] 
  Original Artikel Journal Datum Titel Autoren Alle Autoren
1 [GO] Acta Pharmaceutica Hungarica 2024―Dez―12 Relationship between angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) use with outcome and cardiovascular involvement in patients with COVID-19 Erfan Kazemi, Salman Daliri, Reza Chaman, Marzieh Rohani-Rasaf, Ehsan Binesh, Hossein Sheibani
2 [GO] Acta Pharmaceutica Hungarica 2024―Dez―12 Attitudes toward mask wearing in Malaysia during the COVID pandemic Najmus Sayadat Pitol, Ana Shakirah Sapir
3 [GO] Acta Pharmaceutica Hungarica 2023―Mai―25 Using Space Medicinal Chemistry Against SARS-CoV-2: 
SpaceMedChem Consortium-Project 1. Gergő Mezőhegyi, Balázs Buchholcz, István Puskás, Lajos Szente, Tamás Sohajda, Ferenc Darvas
4 [GO] Acta Pharmaceutica Hungarica 2022―Apr―20 mRNA-Lipid Nanoparticle COVID-19 Vaccines: Structure and Stability Daan J. A. Crommelin
5 [GO] Acta Pharmaceutica Hungarica 2022―Apr―20 Vaccine Development in Global Pandemic Time Tibor Fabó
6 [GO] Acta Pharmaceutica Hungarica 2022―Apr―20 An Academic Approach to Vaccine Development in a Global Pandemic: A Personal Account Allegra Peletta, Eakachai Prompetchara, Chutitorn Ketloy, Gerrit Borchard
 [1] 

6 Ergebisse       Seite 1




[de][en]

Letzte Änderung 2026―Nov―15 17:31:27 UTC

© Daten-Quadrat 2022       Done in 0.008 sec